c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Incyte (INCY) Halts Phase 3 MAESTRA-3 Trial to Refocus Clinical Development
GuruFocus | Nov 13, 2026 5:26 PM EST
Related Stocks: INCY ,
Read original article